rs758356668
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004204.5(PIGQ):āc.634A>Cā(p.Ile212Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000193 in 1,596,166 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_004204.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIGQ | NM_004204.5 | c.634A>C | p.Ile212Leu | missense_variant | 2/11 | ENST00000321878.10 | NP_004195.2 | |
PIGQ | NM_148920.4 | c.634A>C | p.Ile212Leu | missense_variant | 2/10 | NP_683721.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIGQ | ENST00000321878.10 | c.634A>C | p.Ile212Leu | missense_variant | 2/11 | 1 | NM_004204.5 | ENSP00000326674 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152148Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000304 AC: 7AN: 230228Hom.: 0 AF XY: 0.0000394 AC XY: 5AN XY: 127044
GnomAD4 exome AF: 0.000211 AC: 304AN: 1444018Hom.: 0 Cov.: 39 AF XY: 0.000187 AC XY: 134AN XY: 717536
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152148Hom.: 0 Cov.: 34 AF XY: 0.0000404 AC XY: 3AN XY: 74324
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 09, 2022 | The c.634A>C (p.I212L) alteration is located in exon 2 (coding exon 1) of the PIGQ gene. This alteration results from a A to C substitution at nucleotide position 634, causing the isoleucine (I) at amino acid position 212 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Epilepsy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 12, 2022 | This sequence change replaces isoleucine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 212 of the PIGQ protein (p.Ile212Leu). This variant is present in population databases (rs758356668, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with PIGQ-related conditions. ClinVar contains an entry for this variant (Variation ID: 526277). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at